X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (738) 738
Publication (161) 161
Paper (104) 104
Patent (36) 36
Newspaper Article (7) 7
Book / eBook (6) 6
Conference Proceeding (3) 3
Book Chapter (1) 1
Book Review (1) 1
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (325) 325
male (243) 243
index medicus (242) 242
infectious diseases (227) 227
adult (226) 226
female (211) 211
middle aged (174) 174
hiv infections - drug therapy (169) 169
immunology (137) 137
hiv (125) 125
nuclear experiment (113) 113
experiment (111) 111
human immunodeficiency virus--hiv (96) 96
virology (95) 95
physics (91) 91
microbiology (88) 88
treatment outcome (87) 87
drug therapy (85) 85
nuclear physics (80) 80
anti-hiv agents - therapeutic use (77) 77
hiv infections - virology (75) 75
viral load (75) 75
life sciences (74) 74
aids (71) 71
hiv infection (71) 71
aids/hiv (70) 70
high energy physics - experiment (70) 70
antiretroviral therapy (69) 69
aged (65) 65
pharmacology & pharmacy (62) 62
antiretroviral drugs (61) 61
drug therapy, combination (58) 58
health aspects (57) 57
cd4 lymphocyte count (53) 53
emtricitabine (52) 52
therapy (52) 52
tenofovir (51) 51
anti-hiv agents - administration & dosage (50) 50
antiviral agents (50) 50
hiv-1 - drug effects (50) 50
infections (49) 49
particle physics (47) 47
high energy physics (46) 46
infection (46) 46
safety (46) 46
hiv-1 (45) 45
antiretroviral therapy, highly active (43) 43
hiv infections - complications (43) 43
research (43) 43
dosage and administration (42) 42
rna, viral - blood (42) 42
anti-hiv agents - adverse effects (40) 40
human health and pathology (38) 38
efficacy (37) 37
hiv infections - immunology (37) 37
human necessities (36) 36
hygiene (36) 36
medical or veterinary science (36) 36
preparations for medical, dental, or toilet purposes (36) 36
risk factors (36) 36
ritonavir (36) 36
patients (35) 35
[ phys.nexp ] physics [physics]/nuclear experiment [nucl-ex] (34) 34
analysis (34) 34
hiv-1 - genetics (34) 34
mutation (34) 34
adults (33) 33
specific therapeutic activity of chemical compounds ormedicinal preparations (33) 33
adolescent (32) 32
clinical trials (32) 32
chemistry (31) 31
efavirenz (31) 31
france (31) 31
general tagging of cross-sectional technologies spanning over several sections of the ipc (31) 31
general tagging of new technological developments (31) 31
heterocyclic compounds (31) 31
human-immunodeficiency-virus (31) 31
metallurgy (31) 31
organic chemistry (31) 31
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (31) 31
technologies for adaptation to climate change (31) 31
technologies or applications for mitigation or adaptation againstclimate change (31) 31
care and treatment (30) 30
medicine, general & internal (30) 30
risk (30) 30
medicine (29) 29
protease inhibitors (29) 29
viruses (29) 29
drug resistance, viral (28) 28
hepatitis (28) 28
[phys.nexp]physics [physics]/nuclear experiment [nucl-ex] (27) 27
disease (27) 27
drug administration schedule (27) 27
matematikk og naturvitenskap: 400::fysikk: 430::kjerne- og elementærpartikkelfysikk: 431 [vdp] (27) 27
mathematics and natural scienses: 400::physics: 430::nuclear and elementary particle physics: 431 [vdp] (27) 27
prevention (27) 27
reverse transcriptase inhibitors - therapeutic use (27) 27
rna (27) 27
young adult (27) 27
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (26) 26
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (747) 747
French (34) 34
Spanish (12) 12
German (5) 5
Hungarian (2) 2
Icelandic (2) 2
Norwegian (2) 2
Danish (1) 1
Polish (1) 1
Portuguese (1) 1
Russian (1) 1
Slovak (1) 1
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet HIV, ISSN 2352-3018, 05/2018, Volume 5, Issue 5, pp. e206 - e206
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 9, pp. 795 - 807
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 23, pp. 2237 - 2246
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9987, pp. 2606 - 2615
Summary Background Tenofovir disoproxil fumarate can cause renal and bone toxic effects related to high plasma tenofovir concentrations. Tenofovir alafenamide... 
Internal Medicine | KIDNEY-DISEASE | RATES | MEDICINE, GENERAL & INTERNAL | ABACAVIR-LAMIVUDINE | BONE-MINERAL DENSITY | SAFETY | ADULTS | ANTIRETROVIRAL THERAPY | LOPINAVIR/RITONAVIR | COUNT | EXPOSURE | Humans | Male | Thiazoles - administration & dosage | Carbamates - administration & dosage | Arthralgia - chemically induced | Thiazoles - adverse effects | Sleep Initiation and Maintenance Disorders - chemically induced | Tenofovir | Adenine - adverse effects | Quinolones - adverse effects | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Headache - chemically induced | Emtricitabine | Adenine - analogs & derivatives | Kidney - drug effects | Respiration Disorders - chemically induced | Double-Blind Method | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | HIV Infections - virology | Organophosphonates - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | Nausea | Adenine - administration & dosage | Organophosphonates - administration & dosage | Bone Density - drug effects | Quinolones - administration & dosage | Carbamates - adverse effects | HIV Infections - drug therapy | Viral Load - drug effects | Cobicistat | Deoxycytidine - analogs & derivatives | Drug Combinations | Medical colleges | Clinical trials | Cross infection | Nosocomial infections | HIV (Viruses) | Drug therapy | Health aspects | HIV infection | Analysis | Antiretroviral drugs | Infections | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 05/2019
Abstract Background Doravirine (DOR) demonstrated noninferior efficacy to darunavir plus ritonavir (DRV+r) and efavirenz (EFV) in 2 ongoing phase 3 trials:... 
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9835, pp. 2429 - 2438
Summary Background The HIV integrase strand transfer inhibitor elvitegravir (EVG) has been co-formulated with the CYP3A4 inhibitor cobicistat (COBI),... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | TREATMENT-NAIVE | PHARMACOKINETICS | RALTEGRAVIR | SAFETY | EFAVIRENZ | ADULTS | SINGLE-TABLET REGIMEN | PATIENTS 96-WEEK EFFICACY | COMBINATION | ADHERENCE | HIV-1 | Humans | Middle Aged | Male | Thiazoles - administration & dosage | Carbamates - administration & dosage | Anti-HIV Agents - administration & dosage | Tenofovir | Atazanavir Sulfate | Adult | Female | Emtricitabine | Adenine - analogs & derivatives | Pyridines - administration & dosage | Double-Blind Method | Ritonavir - administration & dosage | Deoxycytidine - administration & dosage | Adenine - administration & dosage | Organophosphonates - administration & dosage | Quinolones - administration & dosage | HIV Infections - drug therapy | Oligopeptides - administration & dosage | Cobicistat | Deoxycytidine - analogs & derivatives | Drug Combinations | Antiviral agents | Patient outcomes | Dosage and administration | Research | Comparative analysis | Drug therapy | HIV infection | Anti-HIV agents | Antiretroviral drugs | Bone density | Pharmaceutical industry | Human immunodeficiency virus--HIV | Pneumonia | Laboratories | Ritonavir | Liver | Infections | Drug resistance | Hepatitis | Randomization | All terrain vehicles | Creatinine | Integrase | Data processing | Proteinase inhibitors | Behavior disorders | Ribonucleic acid--RNA | Patients | Cholesterol | Glomerular filtration rate | Inhibitors | Protease inhibitors | Interactive systems
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 238 - 246
Summary Background Efavirenz with tenofovir-disoproxil-fumarate and emtricitabine is a preferred antiretroviral regimen for treatment-naive patients infected... 
Internal Medicine | LAMIVUDINE | MEDICINE, GENERAL & INTERNAL | EFFICACY | SAFETY | COMBINATION THERAPY | GUIDELINES | PROTEASE-INHIBITOR | ANTIRETROVIRAL THERAPY | NEVIRAPINE | REGIMENS | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Adenine - adverse effects | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | Organophosphonates - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Adenine - administration & dosage | Benzoxazines - therapeutic use | Organophosphonates - administration & dosage | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Aged | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Dosage and administration | Efavirenz | Patient outcomes | Clinical trials | Antiretroviral drugs | Drug therapy | Human immunodeficiency virus--HIV
Journal Article
Current Opinion in HIV and AIDS, ISSN 1746-630X, 05/2018, Volume 13, Issue 4, pp. 308 - 314
PURPOSE OF REVIEWThe current review addresses the role of doravirine (DOR), a novel once-daily nonnucleoside reverse transcriptase inhibitor (NNRTI) in... 
nonnucleoside reverse transcriptase inhibitor | antiretroviral naïve | drug resistance | doravirine | INFECTIOUS DISEASES | SINGLE | HEALTHY-SUBJECTS | IMMUNOLOGY | REVERSE-TRANSCRIPTASE INHIBITOR |